Title of article
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
Author/Authors
Anne-Katrin Sjolie، نويسنده , , Ronald Klein، نويسنده , , Massimo Porta، نويسنده , , Trevor Orchard، نويسنده , , John Fuller، نويسنده , , Hans-Henrik Parving، نويسنده , , Rudy Bilous، نويسنده , , Nish Chaturvedi، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
9
From page
1385
To page
1393
Abstract
Summary
Background
Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabetes.
M
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
593605
Link To Document